Smart Biotech Hedge Fund Worth Watching Had Therapeutics MD Before Pop
- Wednesday, July 9, 2014, 8:43
- Market
- Add a comment
Biotech stock Therapeutics MD (TXMD) was up 32.5% on Tuesday, lifted by brokerage house FBR Capital initiating coverage with an incredible $34 price target. Based on TXMD’s Tuesday closing price of $5.47, the FBR price target would mean a 600% return.
http://www.forbes.com/sites/greatspeculations/2014/07/09/smart-biotech-hedge-fund-worth-watching-had-therapeutics-md-before-pop/
About the Author
admin123 has written 23378 stories on this site.
